NeOnc Announces Abu Dhabi DOH Grants IND Status For NEO212, Orally Administered Perillyl Alcohol-Temozolomide Carbamate Conjugate Being Developed For Patients With Aggressive Brain Tumors

뉴스 본문을 불러오고 있어요.

NeOnc Announces Abu Dhabi DOH Grants IND Status For NEO212, Orally Administered Perillyl Alcohol-Temozolomide Carbamate Conjugate Being Developed For Patients With Aggressive Brain Tumors | 웨이프 WAPE

NeOnc Announces Abu Dhabi DOH Grants IND Status For NEO212, Orally Administered Perillyl Alcohol-Temozolomide Carbamate Conjugate Being Developed For Patients With Aggressive Brain Tumors

기사 요약

관련 종목

댓글 —